As the industry prepares for DSCSA 2023 regulations, greater than 50% of Marketing Authorization Holders (MAHs) manufacturing product for the U.S. market are now EPCIS-enabled through the TraceLink’s B2N Integrate-Once™ Network. 

Boston, Mass. (July 27, 2023) – TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000 healthcare and life sciences entities through its B2N Integrate-Once™ network, today announced significant business growth and rapidly accelerating network adoption. With the looming Drug Supply Chain Security Act (DSCSA) compliance deadline on November 27, 2023, pharmaceutical supply chain companies continue to expand digital network connections on the TraceLink network to improve supply chain performance and leverage the extensive serialization and track-and-trace network foundation to tackle the ongoing challenges of drug shortages.

Key highlights of the quarter include:

• 43 new customer accounts and 90 new customer projects initiated for DSCSA compliance.
• 3,115 network links created across 504 companies on the TraceLink network.
• Protected 100,000 patients from drug shortages and saved pharmacies millions of dollars in revenue by predicting shortages in advance with Product Availability Intelligence solution.
• Surpassed one billion DSCSA Transaction Histories processed on the TraceLink network.
• Surpassed one million DSCSA-compliant EPCIS transactions exchanged between trading partners on the TraceLink network.
• Launched the Multienterprise Information Network Tower (MINT) solution to power end-to-end, real-time supply chain visibility and multienterprise process collaboration.
• Launched Supply Chain Work Management for Compliance Exceptions to provide an automated and efficient solution to manage and reconcile DSCSA and other compliance exceptions between trade partners.
• Hosted more than 200 healthcare and life sciences industry professionals from over 75 companies at 30+ sessions at FutureLink 2023. The TraceLink conference focused on DSCSA 2023 readiness plans, emerging opportunities to address drug shortages by leveraging AI with supply chain data, and building a foundation for supply chain digitalization to drive better end-to-end visibility, collaboration, and intelligence. Read More >